The Experimental Animal Core functions as a resource to provide centralized expert services in the design and implementation of gene therapy studies involving experimental animals in accordance with the Institutional Animal Care and Use Committee (IACUC) guidelines. Core F centralizes all experimental animal studies to a pathogen-free, strictly regulated facility from which animals are never removed for the duration of each study. The facility is secured by magnetic card locks and contains 4 animal housing rooms, 2 routine procedure rooms for rodents, one surgical suite for higher mammals including non-human primates, a cash wash center, and support facilities. The Core provides expertise in a wide variety of animal related, gene transfer techniques as well as in depth knowledge of tissue and fluid harvest and analysis. The Core supports all aspects of gene therapy research involving animals including drafting of animal use protocols training and supervising investigators in animal surgical procedures, post-operative veterinary care, and harvest procedures. Husbandry services and environmental and pathogen monitoring are also provided. In addition, the core maintains all supplies for surgical procedures, insures that all work surfaces are cleansed before and after use, and monitors the core facility to insure that all standard operating procedures for the use of the Core facility are followed. The Core provides written standard operating procedures (SOP) for all experimental procedures it supports. Neil Lipman, VMD, the Core Director, possess extensive experience in animal resource program management, including the design and operation of rodent barrier facilities and animal biosafety programs employing viral vectors for gene delivery, insuring that investigators are provided with the highest quality animal resource facility and program in support of their research. Dr. Lipman is responsible for developing and implementing animal health and environmental programs. Ravi Singh, BA, the Core Assistant Director, provides hands-on support for investigators wishing to conduct gene therapy studies involving animals.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01HL066952-02
Application #
6501593
Study Section
Special Emphasis Panel (ZHL1)
Project Start
2001-09-01
Project End
2002-08-31
Budget Start
Budget End
Support Year
2
Fiscal Year
2001
Total Cost
$199,380
Indirect Cost
Name
Weill Medical College of Cornell University
Department
Type
DUNS #
201373169
City
New York
State
NY
Country
United States
Zip Code
10065
Chiuchiolo, Maria J; Crystal, Ronald G (2016) Gene Therapy for Alpha-1 Antitrypsin Deficiency Lung Disease. Ann Am Thorac Soc 13 Suppl 4:S352-69
Nolan, Daniel J; Ginsberg, Michael; Israely, Edo et al. (2013) Molecular signatures of tissue-specific microvascular endothelial cell heterogeneity in organ maintenance and regeneration. Dev Cell 26:204-19
Wang, Lan; Rosenberg, Jonathan B; De, Bishnu P et al. (2012) In vivo gene transfer strategies to achieve partial correction of von Willebrand disease. Hum Gene Ther 23:576-88
Krause, Anja; Whu, Wen Zhu; Xu, Yaqin et al. (2011) Protective anti-Pseudomonas aeruginosa humoral and cellular mucosal immunity by AdC7-mediated expression of the P. aeruginosa protein OprF. Vaccine 29:2131-9
Kobayashi, Hideki; Butler, Jason M; O'Donnell, Rebekah et al. (2010) Angiocrine factors from Akt-activated endothelial cells balance self-renewal and differentiation of haematopoietic stem cells. Nat Cell Biol 12:1046-56
Shmelkov, Sergey V; Hormigo, Adília; Jing, Deqiang et al. (2010) Slitrk5 deficiency impairs corticostriatal circuitry and leads to obsessive-compulsive-like behaviors in mice. Nat Med 16:598-602, 1p following 602
Rabbany, Sina Y; James, Daylon; Rafii, Shahin (2010) New dimensions in vascular engineering: opportunities for cancer biology. Tissue Eng Part A 16:2157-9
Wang, G; Qiu, J; Wang, R et al. (2010) Persistent expression of biologically active anti-HER2 antibody by AAVrh.10-mediated gene transfer. Cancer Gene Ther 17:559-70
Yamamoto, Masaya; James, Daylon; Li, Hui et al. (2010) Generation of stable co-cultures of vascular cells in a honeycomb alginate scaffold. Tissue Eng Part A 16:299-308
Watanabe, M; Boyer, J L; Crystal, R G (2010) AAVrh.10-mediated genetic delivery of bevacizumab to the pleura to provide local anti-VEGF to suppress growth of metastatic lung tumors. Gene Ther 17:1042-51

Showing the most recent 10 out of 61 publications